Study of Efficacy of Bowel Preparation Before Colonoscopy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
California
-
Anaheim, California, United States, 92801
- Advanced Clinical Research Institute
-
-
North Carolina
-
Fayetteville, North Carolina, United States, 28304
- Cumberland Research Associates, LLC
-
-
Virginia
-
Chesapeake, Virginia, United States, 23320
- Gastroenterology Associates of Tidewater
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Are men or nonpregnant women who are scheduled for an elective colonoscopy and who are at least 18 years of age,
- Are, in the opinion of the Investigator, able to communicate with study personnel and comply with the requirements of the study,
- Are able and willing to follow the study-specified testing including the diet and hydration regimen, and
- Have been informed of the nature and risks of the study and have given written informed consent at Screening and before any study-related tests are done.
Exclusion Criteria:
- Have any known contraindications to the study procedures or treatment,
- Have clinically significant active cardiovascular disease, including a history of myocardial infarction, within the past 6 months and/or heart failure
- Have known or suspected electrolyte abnormalities, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus,
- Have any history of prior colon surgery,
- History of active inflammatory bowel disease,
- Have clinical evidence of dehydration,
- Are pregnant or breast-feeding,
- Are unwilling to abstain from alcohol consumption from the day before colonoscopy until discharged from the study,
- Are unwilling to use any prohibited medications, including laxatives, 4 days before receiving the first study dose,
- Have received any investigational agent within 30 days before dosing,
- Have any known or suspected allergies, sensitivity or an unwillingness to consume components of the study medication,
- Known or suspected phenylketonuria (PKU) or sensitivity to products containing phenylalanine, or is on a phenylalanine-reduced diet,
- A history of hemolysis or taking concomitant medications known to precipitate hemolytic reactions,
- Have any other condition which in the Investigator's opinion would make the subject unsuitable for inclusion into the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1
|
Study of Efficacy of Bowel Preparation Before Colonoscopy
|
|
Other: 2
|
Marketed bowel cleanser
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effectiveness of bowel cleansing assessed by the examining physician
Time Frame: During colonoscopy
|
During colonoscopy
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Sherrie McNamara, RN, MSN, MBA, C.B. Fleet Company, Inc.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- PL08.01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.